TriSalus Life Sciences, Inc.
TLSI
$5.10
$0.173.45%
NASDAQ
06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 26.49M | 13.00M | 8.53M | 11.29M | 16.48M |
Total Receivables | 5.57M | 5.45M | 5.09M | 4.91M | 4.71M |
Inventory | 3.81M | 4.16M | 4.05M | 4.00M | 3.44M |
Prepaid Expenses | 2.22M | 2.48M | 3.01M | 3.61M | 3.31M |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -- | -- | -- | -- | -- |
Total Current Assets | 38.08M | 25.10M | 20.67M | 23.81M | 27.94M |
|
|||||
Total Current Assets | 38.08M | 25.10M | 20.67M | 23.81M | 27.94M |
Net Property, Plant & Equipment | 2.81M | 3.11M | 2.88M | 3.25M | 2.95M |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | 1.11M |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | 419.00K | 424.00K | 423.00K | 424.00K | 424.00K |
Total Assets | 41.32M | 28.63M | 23.97M | 27.48M | 32.43M |
|
|||||
Total Accounts Payable | 1.90M | 2.81M | 2.27M | 1.45M | 1.98M |
Total Accrued Expenses | 7.02M | 8.31M | 7.32M | 7.84M | 9.37M |
Short-term Debt | -- | -- | -- | -- | -- |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | 123.00K | 118.00K | 216.00K | 266.00K | 323.00K |
Total Finance Division Other Current Liabilities | 279.00K | 515.00K | 417.00K | 363.00K | 328.00K |
Total Other Current Liabilities | 279.00K | 515.00K | 417.00K | 363.00K | 328.00K |
Total Current Liabilities | 9.32M | 11.75M | 10.23M | 9.92M | 12.00M |
|
|||||
Total Current Liabilities | 9.32M | 11.75M | 10.23M | 9.92M | 12.00M |
Long-Term Debt | 32.27M | 31.70M | 22.08M | 21.68M | 21.29M |
Short-term Debt | -- | -- | -- | -- | -- |
Capital Leases | 1.27M | 1.30M | 1.33M | 1.51M | 1.15M |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | 17.88M | 18.24M | 16.22M | 14.81M | 22.14M |
Total Liabilities | 60.74M | 63.00M | 49.87M | 47.91M | 56.58M |
|
|||||
Common Stock & APIC | 278.79M | 255.55M | 253.66M | 249.01M | 241.78M |
Retained Earnings | -298.21M | -289.92M | -279.55M | -269.44M | -265.93M |
Treasury Stock & Other | -- | -- | -- | -- | -- |
Total Common Equity | -19.42M | -34.37M | -25.89M | -20.43M | -24.15M |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -19.42M | -34.37M | -25.89M | -20.43M | -24.15M |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -19.42M | -34.37M | -25.89M | -20.43M | -24.15M |
|